Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer - Clinical Genitourinary Cancer
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel? - Clinical Genitourinary Cancer
TITAN trials demonstrates significantly Improved Overall Survival and Radiographic Progression-Free Survival for Apalutamide in Patients with Metastatic Castration-Sensitive Prostate Cancer - Onco Americas
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer - European Journal of Cancer
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era - International Journal of Radiation Oncology, Biology, Physics
Recent Advances in the Management of Metastatic Prostate Cancer | JCO Oncology Practice
Overall survival of metastatic prostate cancer patients starting... | Download Scientific Diagram
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.,Prostate Cancer and Prostatic Diseases - X-MOL
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model - European Urology
A) Prostate cancer–specific survival and (B) overall survival... | Download Scientific Diagram
Patients with Localised Prostate Cancer (T1 - T2) Show Improved Overall Long-Term Survival Compared to the Normal Population
Olaparib for Metastatic Castration-Resistant Prostate Cancer | NEJM
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...
Overall survival and prostate cancer specific-survival according to... | Download Scientific Diagram
ASCO GU 2022: The Changing Landscape of Treatment and Survival for Men with Castration-Resistant Prostate Cancer in the Era of Novel Treatments
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England | Prostate Cancer and Prostatic Diseases
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer - Annals of Oncology
PLOS ONE: Overall survival and second primary malignancies in men with metastatic prostate cancer
The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study | Anticancer Research
Overall survival rate of patients with T3a and T3b stage prostate... | Download Scientific Diagram
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial - Annals of Oncology
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018) | BMC Cancer | Full Text
